Keyword: Biocon

FDA

Biocon downplays FDA Form 483 for Bangalore plant

An FDA inspection of a Biocon API plant in Bangalore found a number of issues, but the Indian drugmaker shrugged it off in a statement essentially saying, this is the kind of thing that happens in the regular course of business.